Medexus Pharmaceuticals (MEDXF) Short Interest Ratio & Short Volume $2.32 -0.04 (-1.82%) As of 06/26/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Medexus Pharmaceuticals Short Interest DataMedexus Pharmaceuticals (MEDXF) has a short interest of 3,400 shares. This marks a -61.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 24,585 shares to cover all short positions.Current Short Interest3,400 sharesPrevious Short Interest8,900 sharesChange Vs. Previous Month-61.80%Dollar Volume Sold Short$7.17 thousandShort Interest Ratio0.3 Days to CoverLast Record DateMay 31, 2025Today's Trading Volume12,600 sharesAverage Trading Volume24,585 sharesToday's Volume Vs. Average51% Short Selling Medexus Pharmaceuticals? Sign up to receive the latest short interest report for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDXF Short Interest Over TimeMEDXF Days to Cover Over TimeMEDXF Percentage of Float Shorted Over Time Medexus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20253,400 shares $7.17 thousand -61.8%N/A0.3 $2.11 5/15/20258,900 shares $17.13 thousand +71.2%N/A0.5 $1.93 4/30/20255,200 shares $10.30 thousand -42.2%N/A0.1 $1.98 4/15/20259,000 shares $15.21 thousand -58.9%N/A0.3 $1.69 3/31/202521,900 shares $36.35 thousand -29.6%N/A0.8 $1.66 3/15/202531,100 shares $55.05 thousand +18.7%N/A1.1 $1.77 2/28/202526,200 shares $51.08 thousand +37.2%N/A0.5 $1.95 2/15/202519,100 shares $41.45 thousand -89.4%N/A0.3 $2.17 1/31/2025180,500 shares $480.47 thousand -32.6%N/A1.3 $2.66 1/15/2025267,900 shares $819.77 thousand +76.1%N/A2.8 $3.06 Get the Latest News and Ratings for MEDXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2024152,100 shares $367.32 thousand -3.9%N/A8.2 $2.42 12/15/2024158,200 shares $321.30 thousand -23.8%N/A7 $2.03 11/30/2024207,700 shares $396.71 thousand +133.4%N/A13.9 $1.91 11/15/202489,000 shares $136.17 thousand +16.6%N/A2.9 $1.53 10/31/202476,300 shares $130.02 thousand -16.7%N/A11.9 $1.70 10/15/202491,600 shares $171.29 thousand -20.4%N/A6.6 $1.87 9/30/2024115,000 shares $224.25 thousand -14.8%N/A6.8 $1.95 9/15/2024134,900 shares $269.80 thousand +4.3%N/A6.4 $2.00 8/31/2024129,400 shares $235.51 thousand -12.1%N/A10.7 $1.82 8/15/2024147,200 shares $262.02 thousand -7.6%N/A6.5 $1.78 7/31/2024159,300 shares $275.59 thousand +10.1%N/A9.2 $1.73 7/15/2024144,700 shares $250.91 thousand -8.2%N/A4 $1.73 6/30/2024157,600 shares $209.61 thousand -3.0%N/A10 $1.33 6/15/2024162,500 shares $185.66 thousand +0.8%N/A2.2 $1.14 5/31/2024161,200 shares $188.60 thousand +6.5%N/A9.8 $1.17 5/15/2024151,400 shares $180.17 thousand +26.9%N/A11.4 $1.19 4/30/2024119,300 shares $160.46 thousand +15.2%N/A4.1 $1.35 4/15/2024103,600 shares $118.26 thousand +30.5%N/A2.4 $1.14 3/31/202479,400 shares $96.79 thousand +14.6%N/A3.1 $1.22 3/15/202469,300 shares $81.08 thousand +56.8%N/A2.8 $1.17 2/29/202444,200 shares $58.29 thousand +122.1%N/A2.1 $1.32 2/15/202419,900 shares $27.46 thousand +192.7%N/A0.3 $1.38 1/15/20247,800 shares $15.52 thousand +333.3%N/A0.2 $1.99 12/31/20231,800 shares $3.40 thousand No ChangeN/A0.1 $1.89 11/30/20234,200 shares $4.55 thousand +35.5%N/A0.4 $1.08 11/15/20233,100 shares $4.09 thousand -67.4%N/A0.3 $1.32 10/31/20239,500 shares $13.97 thousand -84.3%N/A0.9 $1.47 10/15/202360,300 shares $108.54 thousand -92.6%N/A6.8 $1.80 9/30/2023814,300 shares $1.82 million -5.6%N/A63.6 $2.24 9/15/2023863,000 shares $2.06 million -6.7%N/A65.9 $2.39Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 8/31/2023925,000 shares $2.00 million +97.5%N/A24.8 $2.16 8/15/2023468,300 shares $894.45 thousand -1.2%N/A8.4 $1.91 7/31/2023474,200 shares $751.61 thousand -0.3%N/A46.5 $1.59 7/15/2023475,600 shares $731.47 thousand +16.2%N/A23 $1.54 6/30/2023409,300 shares $568.93 thousand +0.4%N/A11.2 $1.39 6/15/2023407,600 shares $362.11 thousand -0.6%N/A64.7 $0.89 5/31/2023410,000 shares $378.02 thousand -0.1%N/A64.1 $0.92 5/15/2023410,200 shares $370.37 thousand -1.3%N/A26 $0.90 4/30/2023415,500 shares $400.00 thousand +1.8%N/A62 $0.96 4/15/2023408,200 shares $449.02 thousand -1.0%N/A14 $1.10 3/31/2023412,200 shares $491.47 thousand -0.9%N/A19.8 $1.19 3/15/2023415,800 shares $469.85 thousand +2.0%N/A80 $1.13 2/28/2023407,600 shares $538.03 thousand 0.0%N/A10.1 $1.32 2/15/2023407,700 shares $387.32 thousand +0.0%N/A14.2 $0.95 1/31/2023407,600 shares $574.72 thousand -0.5%N/A10.3 $1.41 1/15/2023409,800 shares $649.53 thousand +4.4%N/A9.9 $1.59 12/30/2022392,600 shares $604.60 thousand -1.3%N/A14.5 $1.54 12/15/2022397,700 shares $562.59 thousand +0.1%N/A12.5 $1.41 11/30/2022397,500 shares $680.76 thousand +11.2%N/A19.1 $1.71 11/15/2022357,500 shares $493.35 thousand +0.3%N/A9.3 $1.38 10/31/2022356,300 shares $381.24 thousand +2.6%N/A15.6 $1.07 10/15/2022347,300 shares $309.10 thousand +37.3%N/A7.1 $0.89 9/30/2022253,000 shares $179.66 thousand +41.7%N/A2.3 $0.71 9/15/2022178,500 shares $255.26 thousand -4.6%N/A12.4 $1.43 8/31/2022187,100 shares $357.36 thousand +298.1%N/A8.5 $1.91 8/15/202247,000 shares $114.68 thousand -23.1%N/A1.8 $2.44 7/31/202261,100 shares $109.98 thousand -17.4%N/A5.4 $1.80 7/15/202274,000 shares $101.59 thousand -15.7%N/A9.6 $1.37 6/30/202287,800 shares $135.21 thousand -3.4%N/A9.4 $1.54 6/15/202290,900 shares $136.39 thousand -16.6%N/A23.3 $1.50 5/31/2022109,000 shares $182.03 thousand +6.2%N/A4.7 $1.67 5/15/2022102,600 shares $218.03 thousand -2.1%N/A13.5 $2.13 4/30/2022104,800 shares $247.85 thousand -0.9%N/A36.1 $2.37 4/15/2022105,700 shares $270.59 thousand -2.3%N/A13.2 $2.56 3/31/2022108,200 shares $271.58 thousand -8.0%N/A12 $2.51 3/15/2022117,600 shares $277.10 thousand -11.0%N/A13.1 $2.36 2/28/2022132,100 shares $344.78 thousand -3.4%N/A6.6 $2.61 2/15/2022136,700 shares $358.15 thousand -7.5%N/A8.5 $2.62 1/31/2022147,700 shares $336.76 thousand +0.5%N/A6.2 $2.28 1/15/2022147,000 shares $313.11 thousand +6.6%N/A7.4 $2.13 12/31/2021137,900 shares $277.18 thousand -4.2%N/A3.5 $2.01 12/15/2021143,900 shares $274.85 thousand +38.6%N/A3.1 $1.91 11/30/2021103,800 shares $223.17 thousand +84.0%N/A2.4 $2.15 11/15/202156,400 shares $133.39 thousand +35.6%N/A1.5 $2.37 10/29/202141,600 shares $110.24 thousand +112.2%N/A1.7 $2.65 10/15/202119,600 shares $55.69 thousand +78.2%N/A0.7 $2.84 9/30/202111,000 shares $26.02 thousand No ChangeN/A0.5 $2.37 8/31/20215,700 shares $18.81 thousand +90.0%N/A0.1 $3.30 8/13/20213,000 shares $9.60 thousand +500.0%N/A0 $3.20 7/30/2021500 shares $2.94 thousand -54.6%N/A0 $5.89Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 7/15/20211,100 shares $6.64 thousand +175.0%N/A0 $6.04 6/30/2021400 shares $2.37 thousand -75.0%N/A0 $5.92 6/15/20211,600 shares $10.57 thousand +100.0%N/A0 $6.61 5/28/2021800 shares $4.85 thousand -11.1%N/A0 $6.06 5/14/2021900 shares $5.18 thousand -52.6%N/A0 $5.75 4/30/20211,900 shares $11.69 thousand +171.4%N/A0 $6.15 4/15/2021700 shares $4.10 thousand -12.5%N/A0 $5.86 3/31/2021800 shares $5.06 thousand -66.7%N/A0 $6.32 3/15/20212,400 shares $13.92 thousand -96.8%N/A0 $5.80 2/26/202175,300 shares $463.85 thousand -1.4%N/A1.5 $6.16 2/12/202176,400 shares $0.00 +159.9%N/A3 $0.00 1/29/202129,400 shares $0.00 +988.9%N/A0.5 $0.00 1/15/20216,300 shares $0.00 +530.0%N/A0.3 $0.00 12/31/20203,300 shares $0.00 -47.6%N/A0.3 $0.00 MEDXF Short Interest - Frequently Asked Questions What is Medexus Pharmaceuticals' current short interest? Short interest is the volume of Medexus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 3,400 shares of MEDXF short. Learn More on Medexus Pharmaceuticals' current short interest. Is Medexus Pharmaceuticals' short interest increasing or decreasing? Medexus Pharmaceuticals saw a decrease in short interest in May. As of May 31st, there was short interest totaling 3,400 shares, a decrease of 61.8% from the previous total of 8,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Medexus Pharmaceuticals stock? Short selling MEDXF is an investing strategy that aims to generate trading profit from Medexus Pharmaceuticals as its price is falling. MEDXF shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medexus Pharmaceuticals? A short squeeze for Medexus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDXF, which in turn drives the price of the stock up even further. How often is Medexus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDXF, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze AVTBF Short Squeeze AVCNF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDXF) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDXF Stock Free MEDXF Stock Alerts